Tamsulosin hydrochloride structure 
             | 
        Common Name | Tamsulosin hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 106463-17-6 | Molecular Weight | 444.973 | |
| Density | N/A | Boiling Point | 595.5ºC at 760 mmHg | |
| Molecular Formula | C20H29ClN2O5S | Melting Point | 228-230ºC | |
| MSDS | Chinese USA | Flash Point | 313.9ºC | |
| Symbol | 
             
            
            GHS07  | 
        Signal Word | Warning | |
            Use of Tamsulosin hydrochlorideTamsulosin hydrochloride((R)-(-)-YM12617;LY253351) is a selective α1 receptor antagonist.Target: α1 receptorTamsulosin is a selective α1 receptor antagonist that has preferential selectivity for the α1A receptor in the prostate versus the α1B receptor in the blood vessels. Tamsulosin-treated patients had a 0.30-fold lower risk of developing acute urinary retention compared with control patients. None of the International Continence Society male questionnaire domain scores showed significant changes between the groups [1]. tamsulosin can be recommended for treating men after catheterization for AUR, and can reduce the likelihood of the need for re-catheterization [2].  | 
    
| Name | tamsulosin hydrochloride | 
|---|---|
| Synonym | More Synonyms | 
| Description | Tamsulosin hydrochloride((R)-(-)-YM12617;LY253351) is a selective α1 receptor antagonist.Target: α1 receptorTamsulosin is a selective α1 receptor antagonist that has preferential selectivity for the α1A receptor in the prostate versus the α1B receptor in the blood vessels. Tamsulosin-treated patients had a 0.30-fold lower risk of developing acute urinary retention compared with control patients. None of the International Continence Society male questionnaire domain scores showed significant changes between the groups [1]. tamsulosin can be recommended for treating men after catheterization for AUR, and can reduce the likelihood of the need for re-catheterization [2]. | 
|---|---|
| Related Catalog | |
| References | 
| Boiling Point | 595.5ºC at 760 mmHg | 
|---|---|
| Melting Point | 228-230ºC | 
| Molecular Formula | C20H29ClN2O5S | 
| Molecular Weight | 444.973 | 
| Flash Point | 313.9ºC | 
| Exact Mass | 444.148560 | 
| PSA | 108.26000 | 
| LogP | 4.51290 | 
| Vapour Pressure | 3.79E-14mmHg at 25°C | 
| Storage condition | Desiccate at RT | 
                                    CHEMICAL IDENTIFICATION
 
 
 
 
 
 
 HEALTH HAZARD DATAACUTE TOXICITY DATA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  | 
                            
| Symbol | 
                                    
                                     
                                    
                                    GHS07  | 
                            
|---|---|
| Signal Word | Warning | 
| Hazard Statements | H302-H315-H319-H335 | 
| Precautionary Statements | P301 + P312 + P330-P305 + P351 + P338 | 
| Hazard Codes | Xn | 
| Risk Phrases | 22-36/37/38 | 
| Safety Phrases | 26 | 
| RIDADR | NONH for all modes of transport | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            Tamsulosin hydr... CAS#:106463-17-6  | 
                                
| Literature: EP2172443 A1, ; Page/Page column 12 ; | 
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| 
                                    
                                    Inhibition of smooth muscle force generation by focal adhesion kinase inhibitors in the hyperplastic human prostate.
                                    
                                    
                                     Am. J. Physiol. Renal Physiol. 307(7) , F823-32, (2014) Smooth muscle contraction may be critical for lower urinary tract symptoms (LUTS) in patients with benign prostate hyperplasia and requires stable anchorage of the cytoskeleton to the cell membrane. T...  | 
                                |
| 
                                    
                                    Effects of alpha1-adrenoceptor antagonist (tamsulosin) on incident of ejaculation and semen quality in the goat.
                                    
                                    
                                     Andrologia 47(3) , 354-9, (2015) Male temporary contraception is occasionally required in some animals. Alpha1-adrenoceptor antagonist (tamsulosin) can cause ejaculation disorder. Two sets of Latin square were applied to six male goa...  | 
                                |
| 
                                    
                                    Pharmacokinetic interaction of finasteride with tamsulosin hydrochloride: an open-label, randomized, 3-period crossover study in healthy Chinese male volunteers.
                                    
                                    
                                     Clin. Ther. 37(2) , 462-72, (2015) The primary aim of this study was to evaluate whether there was clinically significant pharmacokinetic (PK) interaction between finasteride and tamsulosin in healthy Chinese male subjects.This was an ...  | 
                                
| TAMSULOSINHCL | 
| TAMSOLUSIN HYDROCHLORIDE | 
| YM 12617-1 | 
| (R)-Tamsulosin | 
| (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide hydrochloride | 
| 5-[(2R)-2-{[2-(2-Ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzolsulfonamidhydrochlorid | 
| Tamsulosin HCl | 
| Tamsulosin hydrochloride | 
| Yutanal | 
| YM-617 | 
| UNII:11SV1951MR | 
| 5-[(R)-2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]]-2-methoxybenzenesulfonamide Hydrochloride | 
| (R)-TAMSULOSIN HCL | 
| 5-[(2R)-2-[[2-(2-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide hydrochloride | 
| Yutana | 
| TAMSULOSINE HYDROCHLORIDE | 
| FLOMAX | 
| benzenesulfonamide, 5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-, monohydrochloride | 
| Benzenesulfonamide, 5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-, hydrochloride (1:1) | 
| TAMSULOSIN HYDROCHLORIDE , CERTIFIED REFERENCE MATERIAL | 
| Tamsulosin (hydrochloride) | 
| MFCD00922997 | 
| PRADIF | 
| (R)-TAMSULOSIN HYDROCHLORIDE,WHITE TO OFF-WHITE SOLID | 
| (R)-Tamsulosin Hydrochloride | 
| (R)-5-[2-[[2-(2-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide monohydrochloride | 
| TAMSOLUSIN HCL | 
| 5-[(2R)-2-{[2-(2-Ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide hydrochloride (1:1) | 
| (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide monohydrochloride | 
| HARNAL | 
| OMNIC | 
| (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide hydrochloride ee | 
| 5-[(2R)-2-{[2-(2-éthoxyphénoxy)éthyl]amino}propyl]-2-méthoxybenzènesulfonamide chlorhydrate | 
| Omic |